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Abstract
Background: An area of ongoing controversy is the role adenosine to regulate vascular tone in conduit vessels
that regulate compliance, and the role of nitric oxide (NO), potassium channels and receptor subtypes involved.
The aim of our study was to investigate adenosine relaxation in rat thoracic aortic rings, and the effect of inhibitors
of NO, prostanoids, Kv, KATP channels, and A2a and A2b receptors.
Methods: Aortic rings were freshly harvested from adult male Sprague Dawley rats and equilibrated in an organ
bath containing oxygenated, modified Krebs-Henseleit solution, 11 mM glucose, pH 7.4, 37 °C. Isolated rings were
pre-contracted sub-maximally with 0.3 μM norepinephrine (NE), and the effect of increasing concentrations of
adenosine (1 to 1000 μM) were examined. The drugs L-NAME, indomethacin, 4-aminopyridine (4-AP), glibenclamide,
5-hydroxydecanoate, ouabain, 8-(3-chlorostyryl) caffeine and PSB-0788 were examined in intact and denuded rings.
Rings were tested for viability after each experiment.
Results: Adenosine induced a dose-dependent, triphasic relaxation response, and the mechanical removal of the
endothelium significantly deceased adenosine relaxation above 10 μM. Interestingly, endothelial removal significantly
decreased the responsiveness (defined as % relaxation per μM adenosine) by two-thirds between 10 and 100 μM, but
not in the lower (1–10 μM) or higher (>100 μM) ranges. In intact rings, L-NAME significantly reduced relaxation, but not
indomethacin. Antagonists of voltage-dependent Kv (4-AP), sarcolemma KATP (glibenclamide) and mitochondrial KATP
channels (5-HD) led to significant reductions in relaxation in both intact and denuded rings, with ouabain having little
or no effect. Adenosine-induced relaxation appeared to involve the A2a receptor, but not the A2b subtype.
Conclusions: It was concluded that adenosine relaxation in NE-precontracted rat aortic rings was triphasic and
endothelium-dependent above 10 μM, and relaxation involved endothelial nitric oxide (not prostanoids) and
a complex interplay between smooth muscle A2a subtype and voltage-dependent Kv, SarcKATP and MitoKATP
channels. The possible in vivo significance of the regulation of arterial compliance to left ventricular function
coupling is discussed.
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Background
Adenosine is a ubiquitous endogenous mediator that is
activated in response to cellular ischemic/hypoxic/shear
stress [1–5]. Adenosine exerts it cellular effects by binding
to four major subtypes of the G-protein-coupled recep-
tors; A1, A2a, A2b, and A3 which activate intracellular
survival kinase pathways in a cell- and tissue-specific man-
ner [2, 3, 5, 6]. Through receptor-modulation and down-
stream signaling pathways adenosine alters coronary and
peripheral vascular tone, cardiac function, brain and cen-
tral nervous system signalling, sleep, the state of natural
hibernation, ischemic preconditioning, post-conditioning,
inflammation, coagulation, angiogenesis and cell prolifera-
tion and remodelling [4–7].
An area of ongoing controversy is the role adenosine to
regulate vascular tone in the arterial tree, and the receptor
subtypes involved. The subtype A2a appears to be the pre-
dominate receptor in arterial vasodilation in mouse, rat,
guinea pig, pigs and humans, however, the A2b receptor
has also been reported to dilate human coronary arter-
ies [8], and possibly rat coronary arteries [6]. In the
guinea pig, A2b appears to predominate in the thoracic
aorta to induce relaxation [9] and both A2a and A2b in
the rat [10–12]. In addition, there is ongoing debate on
the relative importance of an intact endothelium to
adenosine relaxation in these vessels, and the role of
nitric oxide (NO) and interplay between voltage-
dependent transmembrane Na+, K+ and Ca2+ fluxes and
signalling pathways. In the thoracic aorta, adenosine re-
laxation has been reported to be fully dependent [10,
13], partially dependent [14–17] or not dependent on
the presence of an intact endothelium [10, 18–20].
Adenosine vasodilation has also been linked to A1 and
A2a receptor activation of endothelial production of NO
and prostanoids [21], hyperpolarising factors [4], and a
complex interplay between endothelial and smooth
muscle mitochondrial and sarcolemmal KATP channels
[16, 22, 23], and Na+/K+ ATPase activation [4, 24].
The aim of the present study was to investigate adeno-
sine relaxation in intact versus denuded rat thoracic aortic
rings, and examine the effect of inhibitors of nitric oxide
(NO), prostanoids, Kv channels, KATP channels, and ad-
enosine A2a and A2b receptors. The rat thoracic aorta was
chosen because of the ongoing debates about the mecha-
nisms of adenosine relaxation, and its in vivo significance.
Methods
Animals
Male Sprague Dawley rats (300–350 g, n = 47) were fed
ad libitum and housed in a 12-h light/dark cycle. On the
day of the experiment rats were anaesthetised with Na-
thiopentone (100 mg/kg). Animals were treated in accord-
ance with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1996). The James
Cook University (JCU) Animal Ethics Committee ap-
proval number for the present study was A1535. All
other chemicals, drugs and inhibitors including adeno-
sine (A9251 > 99 % purity) were purchased from Sigma
Aldrich (Castle Hill, NSW).
Aortic ring preparation and organ bath tension
measurements
The thoracic cavity of anesthetized rats was opened and
the thoracic aorta was harvested and placed in a modi-
fied ice-cold solution of Krebs-Henseleit (118 mM NaCl,
4.7 mM KCl, 1.2 mM Na2PO4, 0.5 mM MgCl2, 1.12 mM
CaCl2, 25 mM NaHCO3, 0.03 mM EDTA) pH 7.4 with
11 mM glucose. The aorta was carefully dissected from
surrounding fat and connective tissue and cut into short
transverse segments. Intact aortic rings were isolated
from each rat and used without further processing. In
those studies that required removal of the endothelium,
intact rings were denuded by gently rubbing the intimal
surface of the vessel segment with a smooth metal probe.
Successful removal of the endothelium was assessed by
testing the aortic ring for a vasodilatory response to
10 μM acetylcholine (final concentration).
After preparation, intact or denuded aortic rings (3 to
4 mm long) were equilibrated in a standard 10 ml vol-
ume organ bath (Radnoti Glass, ADinstruments, NSW,
AUS) containing modified Krebs-Henseleit (see above)
and continuously bubbled with 95 % O2 and 5 % CO2 at
37 °C for 15 min (zero tension). The rings were vertically
mounted on small stainless steel triangles, stirrups and
connected to an isometric force transducer (PANLAB,
distributed by ADInstruments as MLT 0201/RAD,
NSW, AUS) coupled to a computer based data acquisi-
tion system (PowerLab, ADInstruments) and data re-
cording software LabChart 7 (ADInstruments Pty Ltd.,
Castle Hill, Australia).
The ring tension was manually adjusted to 1.5 g and
equilibrated for 60 min. A tension of 1.5 g was chosen
from the literature for thoracic aortic rings [25, 26]
and preliminary studies verified this tension. During
equilibration, the solution was changed in 15 min in-
tervals. The aortic rings were then washed with freshly
prepared Krebs Henseleit buffer pH 7.4 and the ten-
sion was readjusted to 1.5 g tension. Each preparation
was sub-maximally contracted using 3 μl of 0.1 mM
NE (0.3 μM final concentration) [27, 28]. Those aortic
rings that failed to contract were discarded. Ten micro-
liters of 10 mM acetylcholine (10 μM final concentra-
tion) was applied to confirm the presence or absence of
an intact endothelium in all preparations. Acetylcholine
will induce rapid relaxation of precontracted rings if
the endothelium is intact and if the endothelium is re-
moved (or denuded) the rings will remain in contracted
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state [19]. Aortic rings were considered intact if the re-
laxation induced by 10 μM ACh was greater than 80 %,
and the aortic ring was assumed denuded if relaxation
was less than 10 %.
Rings were contracted at least two more times before
each experiment until a reproducible contractile re-
sponse was obtained. Ten to 15 min after this state was
achieved the experiment was commenced because pre-
liminary studies showed that the increase in tension and
plateau from 0.3 μM of NE was reached at 10 min and
remained at this plateau level for over 60 min, the time
course of each experiment.
Adenosine relaxation in intact and denuded rat aortic rings
Adenosine was added into the oxygenated organ bath
containing Krebs-Henseleit solution to obtain 1, 5, 10, 50,
100, 500 and 1000 μM adenosine concentrations. The
change in tension of pre-contracted intact or denuded
rings was measured. The inhibitors used in this study were
incubated in organ bath 20–30 min before NE was admin-
istered followed by adenosine incremental administration.
These included 1) 100 μM NG-nitro-L-arginine Methyl
Ester (L-NAME) (nitric oxide synthetase inhibitor) and
10 μM indomethacin (cyclooxygenase or prostaglandin in-
hibitor e.g. prostacyclin). NO and prostacyclin are two
major endothelial derived relaxation factors (EDRF), and
the inhibitors were only applied in endothelium intact aor-
tic rings, and 2) 1 mM 4-aminopyridine (4-AP) (Non-se-
lective voltage-dependent K+-channel blocker of the Kv1
to Kv4 families rather than Kv7 channels) [29–31], 10 μM
glibenclamide (Non-selective SarcKATP channel blocker)
[32, 33] and 1 mM 5-hydroxydecanoate (5-HD) (Mito-
KATP channel blocker) [34], and Na
+/K+-ATPase inhibitor
(100 μM ouabain) [24]. These inhibitors were applied to
intact endothelium rings in the presence of L-NAME and
indomethacin, and without the presence of L-NAME and
indomethacin in denuded aortic rings. The adenosine A2a
receptor inhibitor was 100 μM 8-(3-chlorostyryl) caf-
feine (CSC) [35, 36], and the A2b receptor inhibitor was
10 μM 8-(4-(4-(4-chlorobenzyl)piperazine-1-sulfonyl)-
phenyl)-1-propylxanthine (PSB-0788) [37]. In rat stri-
atal membranes, these antagonists have reported Ki
values of 24 nM for CSC [38] and 0.393 nM for PSB-
0788 [37], and the micromolar concentrations used in
the present study were based on previous published
studies [39–41]. The inhibitors were applied in endo-
thelium intact and denuded aortic rings in an oxygen-
ated medium. At the end of each experiment, the rings
were tested for viability (or patency) by being max-
imally dilated with 100 μM papaverine, and relaxation
was expressed as percentage of maximal relaxation to
papaverine [24, 42].
Statistics
Values are expressed as mean ± SEM. Eight animals (n = 8)
were used for each group for seven measurement
points using ANOVA analysis, and the number of rats
was selected from a priori G-power analysis to achieve
a level of 1.0. All data was tested for normality using
Kolmogorov-Smirnov test. Relaxation responses to ad-
enosine were analysed for homogeneity of variances
followed by two-way ANOVA coupled with the Bonferroni
post-hoc test for individual data point comparisons. The
alpha level of significance for all experiments was set at
p < 0.05.
Results
Intact versus denuded aortic rings
In endothelium-intact rat aortic rings, adenosine led to
10, 21, 29, 60 and 81 % relaxation at 10, 50, 100, 500,
and 1000 μM adenosine concentrations respectively
(Fig. 1). Adenosine relaxation in intact rings occurred in
three linear phases (log scale); 0.96 % per μM from 1 to
10 μM adenosine (Phase 1), 0.2 % per μM from 10 to
100 μM adenosine (Phase 2), and 0.06 % per μM from
100 to 1000 μM (Phase 3). After removing the endothe-
lium, relaxation was reduced to 8, 10, 14, 45 and 67 %
respectively, and was significant from 100 to 1000 μM.
In denuded rings, adenosine relaxation was 0.72 % per
μM from 1 to 10 μM adenosine, 0.07 % per μM from 10
to 100 μM adenosine (Phase 1), and 0.06 % per μM in
Phase 2 from 100 to 1000 μM. Thus endothelial removal
of rat aortic rings decreased the responsiveness (defined























Phase 1 Phase 2 Phase 3
Fig. 1 Concentration response curves to adenosine in intact and
denuded isolated rat aortic rings. Relaxation is expressed as percent
of maximal relaxation to 100 μM papaverine. Points represent mean
± S.E.M of aortic rings from a total of seven animals. *P < 0.05
statistical difference in responses between the intact and denuded
rings. Symbols (♦) Intact rings (■) Denuded rings
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and 100 μM, but not in the lower (Phase 1) or higher
(Phase 3) ranges (Fig. 1).
Intact aortic rings
Effect of L-NAME and indomethacin
Figure 2 shows that L-NAME and indomethacin signifi-
cantly reduced adenosine relaxation at 50 to 1000 μM
adenosine. At 50 μm, relaxation decreased from 26 to
11 % or 42 % (11/26 × 100) of the relaxation of intact con-
trols. Thus at 50 μM adenosine 59 % of relaxation was
linked to L-NAME and indomethacin inhibition. At 100,
500 and 1000 μM adenosine concentrations, L-NAME
and indomethacin contribution to inhibition were 53, 33
and 19 % (Fig. 2). In addition, experiments with L-NAME
alone showed a similar inhibition, indicating that indo-
methacin had little or no significant inhibition (Fig. 2).
However, at 500 uM and 1000 uM adenosine there was a
small difference of indomethacin from L-NAME but not
significant (Fig. 2).
Effect of Kv, SarcKATP, MitoKATP blockers and ouabain on
adenosine relaxation
The effect of Kv, sarcKATP, mitoKATP channels and Na
+/K+-ATPase on adenosine relaxation in intact aortic
rings is shown in Fig. 3a–d. In order to eliminate the
effect of NO- and prostacyclin-induced relaxation in
intact rings, 100 μM L-NAME and 10 μM indometh-
acin were included in the controls.
Kv inhibition
Pre-incubating intact rings with 1 mM 4-aminopyridine
(4-AP) on adenosine relaxation is shown in Fig. 3a.
Percentage relaxation was 2.4, 5.1, 8.0, 32.1 and 52.5 %
for 10, 50, 100, 500 and 1000 μM adenosine, respectively.
Expressed as a percentage contribution of adenosine re-
laxation relative to control intact rings, the Kv channel
was responsible for 78, 73, 72, 58.2 and 28 % for 10, 50,
100, 500 and 1000 μM adenosine respectively, with greater
between 10 to 100 μM (Fig. 3a).
SarcKATP and MitoKATP inhibition
The effect of glibenclamide on adenosine relaxation is
shown in Fig. 3b. Glibenclamide was not as striking as
4-AP but significantly decreased adenosine relaxation at
50 and 100 μM adenosine. The contribution of sarcKATP
channel to adenosine relaxation was 63, 53 and 38 % at
10, 50 and 100 μM adenosine (Fig. 3b). MitoKATP in-
hibitor, 5-hydroxydecanoate (5-HD), significantly led to
a wider range of inhibition of adenosine relaxation
compared to glibenclamide from 10 to 1000 μM, but
the differences between the two blockers were not sig-
nificant (Fig. 3c). The contribution of mitoKATP channel
to adenosine relaxation was 70, 63, 65, 40 and 27 % at
10, 50, 100, 500 and 1000 μM adenosine level (Fig. 3c).
Na+/K+-ATPase inhibition
Figure 3d showed that ouabain did not significantly
change the inhibition produced by L-NAME and indo-
methacin in adenosine-induced relaxation at any given
concentration, indicating that Na+/K+-ATPase contrib-
uted little extra to adenosine relaxation in endothelium
intact aortic rings.
Effect of A2a and A2b blockers in intact and denuded
aortic rings
Intact rings
L-NAME and indomethacin were not included in this ex-
periment because it has been reported that NO or prosta-
cyclin release are linked to adenosine A2a,b receptor
activation [43]. In the absence of any inhibitors, adenosine
induced a rate of relaxation of about 10 % for every
50 μM adenosine up to 100 μM, and ~25 % relaxation per
50 μM from 100 to 1000 μM until 90 % full relaxation
(Fig. 4a). Pre-incubating intact rings with adenosine A2a
receptor inhibitor, CSC, significantly reduced adenosine
relaxation between 50 to 100 μM (Fig. 4a). Although
greater percentage falls in relaxation occurred at lower ad-
enosine levels (e.g. 5 to 10 μM) these were not signifi-
cantly different from controls (Fig. 4a). The A2a receptor
was responsible for 71, 66, 59 and 47 % adenosine relax-
ation at 5, 10, 50, and 100 μM adenosine, respectively. In
direct contrast, adenosine A2b receptor inhibitor, PSB
0788, did not change relaxation at any adenosine concen-
tration studied (Fig. 4b).
Denuded rings
In denuded rat aortic rings, incubation with A2a blocker,
CSC, showed a significant reduction of adenosine relax-
ation from 5 to 100 μM (Fig. 4b). At 5, 10, 50 and
























Fig. 2 Concentration-response curves to adenosine with and without
the presence of L-NAME alone and L-NAME + indomethacin in intact
isolated rat aortic rings. Relaxation is expressed as percent of maximal
relaxation to 100 μM papaverine. Points represent mean ± S.E.M of
aortic rings from a total of eight animals. *P < 0.05 statistically different
in the presence of L-NAME alone (▲) and L-NAME+ indomethacin (■)
compared to control on intact rings (♦)
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72, 79, 66 and 55 % reduction in relaxation. Similar to 4-
AP and 5-HD, the A2a receptor blocker did not inhibit
adenosine relaxation at 500 uM and 1000 uM. In con-
trast, adenosine A2b blocker, PSB 0788, had no effect to
reduce adenosine-induced relaxation (Fig. 4b).
Effect of Kv, SarcKATP, MitoKATP blockers and ouabain on
adenosine relaxation in denuded rings
In the absence of endothelium and blockers, adenosine re-
laxed rat aortic rings in a dose-dependent manner and
reaching 78 % relaxation at the highest 1000 μM adenosine
concentration (Fig. 5). Pre-treatment with 4-AP signifi-
cantly reduced relaxation from 1 to 500 μM adenosine but
not at 1000 μM (Fig. 5a). 4-AP nearly completely abolished
adenosine-induced relaxation up to 10 μM adenosine with
over 95 % inhibition. At 50, 100 and 500 μM adenosine,
the Kv channel was responsible for 74 %, 62 %, 21 % of ad-
enosine relaxation (Fig. 5a).
The sarcKATP channel blocker, glibenclamide, also sig-
nificantly reduced relaxation at 10, 50 and 100 μM adeno-
sine levels (Fig. 5b) indicating that the SarcKATP channel
was responsible for 41, 38 and 22 % of adenosine relax-
ation, respectively. Mitochondrial KATP blocker, 5-HD,
significantly reduced relaxation over a wider range than
glibenclamide similar to intact rings (Figs. 3b, c and 5b, c).
The greatest effect of 5-HD was found at 10 to 100 μM.
The contributions of the mitoKATP channel to adenosine
relaxation were 51, 48, 44 and 14 % at 10, 50, 100 and 500
uM adenosine levels, respectively. The Na+/K+-ATPase























































a 4-AP Voltage-dependent K+ (Kv)
channel blocker
c 5HD (MitoKATP blocker) 
b Glibenclamide (SarcKATP blocker)
d Oubain Na+/K+-ATPase blocker





Fig. 3 Concentration-response curves to adenosine with and without the presence of some specific ion channel blockers in intact isolated rat
aortic rings. a In the presence of 1 mM 4-aminopyridine (■). b In the presence of 1 mM 5-Hydroxydecanoate (■). c In the presence of 10 μM
glibenclamide (■). d In the presence of 100 μM ouabain (■) compared to controls intact rings (♦). Relaxation is expressed as percent of maximal
relaxation to 100 μM papaverine. Points represent mean ± S.E.M of aortic rings from a total of eight animals. *P < 0.05 statistical difference in
responses between the presence and the absence of inhibitors on intact rings
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no significant effects to reduce adenosine-induced vaso-
dilation at any given adenosine level (Fig. 5d).
Discussion
Despite decades of investigation, the mechanisms of ad-
enosine relaxation in large elastic arteries such as the rat
thoracic aorta, and smaller muscular resistance arterioles
are not fully understood [3, 4, 6, 19, 44]. We report in iso-
lated rat thoracic rings that adenosine vasodilation was: 1)
triphasic and partially dependent on an intact endothe-
lium, 2) regulated predominately by endothelial NO, not
prostanoids, 3) dependent on opening smooth muscle Kv,
SarcKATP and MitoKATP channels, 4) ouabain-insensitive
(Na+/K+ ATPase), and 5) activated by the A2a subtype, not
A2b. We discuss the possible interplay between these po-
tassium channels and adenosine relaxation in denuded
and intact aortic rings, and the in vivo significance.
Adenosine relaxation involves an NO-dependent pathway
Our study showed that L-NAME significantly reduced re-
laxation in intact rings and contributed up to 59 % of ad-
enosine relaxation with little or no effect of indomethacin
(Fig. 2). In the rat aorta, endothelial NO is believed to
induce vasodilation via cGMP- and cAMP-dependent pro-
tein kinase mechanisms, and the inhibition of Rho-kinase
constrictor activity [45]. The lack of a prostanoid effect in
our study was surprising. In 2002, Ray and colleagues
showed in an elegant series of studies, using a NO-
sensitive electrode, that adenosine relaxation in the rat
aorta produced a dose-dependent NO release from the
endothelium [46]. They further showed that A1-receptor
NO release was linked to endothelial prostacyclin release
via a common cyclic AMP signalling pathway [21].
In contrast to our study, Ray and colleagues used
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Fig. 4 Concentration-response curves to adenosine with and without the presence of adenosine A2ab receptor blockers in intact (a) and
denuded (b) isolated rat aortic rings. In the presence of 100 μM 8-(3-Chlorostyryl) caffeine (■) or 10 μM PSB 0788 (■). Controls (intact and
denuded rings) (♦). Relaxation is expressed as percent of maximal relaxation to 100 μM papaverine. Points represent mean ± S.E.M of aortic rings
from a total of eight animals. *P < 0.05 statistical difference in responses between the presence and the absence of inhibitors on intact rings
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rats, and aortic conduits of 10 mm in length which
were longitudinally opened and the NO-sensitive elec-
trode directly in contact with the endothelial surface
[21, 46]. Systemic hypoxia in their study was induced
using 8 % O2 in N2 for 5 min prior to aorta harvest,
but the group did not specify the pO2, pCO2 or
temperature of their bathing media. This is an interest-
ing contrast, as we harvested the thoracic aorta from
normoxic, male 300-350 g Sprague Dawley rats under
thiopentone anesthesia, and our isolated intact rings
were 3–4 mm in length and fully oxygenated at all
times. It is possible that prostanoid production in rat aor-
tic rings is not activated during normoxia but during hyp-
oxia. In 2001, Verma and colleagues also reported in
healthy humans that COX-2–selective inhibition did not
result in significant changes in endothelial vasodilator re-
sponses [47]. Further work is required to examine these
differences in different models.
Role of the endothelium to adenosine relaxation
In the present study, adenosine vasodilation was partially




























































a -AP Voltage-dependent K+ (Kv)
channel blocker
c ATP blocker) 
b ATP blocker) 
d Ouabain Na+/K+-ATPase blocker 







Fig. 5 Concentration-response curves to adenosine with and without the presence of some specific ion channel blockers in denuded isolated rat
aortic rings. a In the presence of 1 mM 4-aminopyridine (■). b In the presence of 1 mM 5-Hydroxydecanoate (■). c In the presence of 10 μM
glibenclamide (■). d In the presence of 100 μM ouabain (■). Control denuded rings (♦). Relaxation is expressed as percent of maximal relaxation
to 100 μM papaverine. Points represent mean ± S.E.M of aortic rings from a total of eight animals. *P < 0.05 statistical difference in responses
between the presence and the absence of inhibitors on denuded rings
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earlier work of Yen and colleagues [14], Moritoki et al.,
[15], Headrick and Berne [16] and Rose’Meyer and col-
leagues [17] in rat and guinea pig thoracic aorta. However,
we showed that adenosine relaxation was triphasic (Fig. 1),
and that endothelial removal reduced ring relaxation ‘re-
sponsiveness’ between 10 to 100 μM adenosine (Phase 2)
with little or no change to denuded ring sensitivity from 1
to 10 μM (Phase 1) or from 100 to 1000 μM (Phase 3)
compared to intact rings (Fig. 1). To our knowledge, this
triphasic nature of adenosine relaxation has not been re-
ported before, and although the underlying mechanisms
for the different sensitivities are not known, they appear
to involve differential endothelial-smooth muscle sensitiv-
ities to endothelial NO production, and smooth muscle
A2a receptor and voltage-dependent Kv and KATP channels
(see below).
Role of voltage-dependent Kv channels in adenosine
relaxation
The 4-AP experiments (~70-95 % inhibition at 5 to
100 μM adenosine) demonstrated that the Kv channel has
the potential to be a potent activator of adenosine relax-
ation in rat aortic rings. A similar change in intact and
denuded rings (Figs. 3a and 5a) suggests that 4-AP effect
was independent of endothelial NO production, and was
preferentially activated on vascular smooth muscle (Fig. 3a).
Our data support the study of Tammaro and colleagues
who reported the presence of smooth muscle Kv channels
in rat aorta [48], and that of Heapes and Bowles in swine
coronary arteries who showed 4-AP-sensitive K+ channels
in adenosine relaxation [49]. In addition, Kv channels have
also been widely reported in regulating tone in smaller re-
sistance vessels of cerebral and mesenteric vascular beds
[31, 50–52], and in vascular smooth muscle from larger rat
pulmonary arteries [53]. In conclusion, our data indicate
that adenosine relaxation in isolated NE-precontracted rat
aortic rings involved Kv channels with higher sensitivities
found at lower adenosine levels. Further studies are re-
quired using more specific Kv channel isoform inhibitors
(and agonists), and their membrane voltage dependence on
relaxation [54] at low and high adenosine levels.
Contributions of SarcKATP and MitoKATP channels to
adenosine relaxation, and A2a receptor activation
We further showed that the SarcKATP channel contrib-
uted to 14 to 63 % of adenosine relaxation up to
100 μM adenosine (Figs. 3b and 5b), and MitoKATP
channels contributed to 22 to 70 % relaxation up to
1000 μM adenosine in intact and denuded aortic rings
(Figs. 3c and 5c). The wider range of adenosine inhib-
ition with MitoKATP channel blocker 5-HD indicates
that it shifted the control relaxation curve more to the
right than glibenclamide (Figs. 3c and 5c). For example,
at 10 and 100 μM adenosine, 5-HD led to 50 % more
inhibition than glibenclamide in intact rings (Fig. 5c, b),
and 17 and 29 % more inhibition in denuded rings
(Fig. 5c, b). This difference may indicate differential
contributions of the MitoKATP and SarcKATP channel
activation to adenosine relaxation, however, 5-HD has
been shown to exert effects independent of MitoKATP
channels [55] which may influence that interpretation.
Our glibenclamide data showing significant relaxation
reduction (Figs. 3b and 5b), albeit less potent than 5-HD
(Figs. 3c and 5c), is in contrast to the study of Husken
and colleagues who reported no effect in rat aorta [56].
However, their rings were bathed in a hypoxic, low-
glucose medium. Similarly Kemp and Cocks reported
lack of a glibenclamide effect in coronary artery rings
prepared from cardiac surgery patients [8]. It appears
therefore that glibenclamide-sensitive KATP channel acti-
vation and adenosine relaxation is dependent on the
state of tissue oxygenation, prior disease states and pos-
sibly ischemia.
Furthermore, Kemp and Cocks found that adenosine
relaxation in their discarded human coronary artery
rings was mediated largely by A2b receptors [8], unlike
A2a receptors we found in isolated rat aortic rings
(Fig. 4a, b). Adenosine A2a receptor activation and relax-
ation in rat aortic rings is consistent with the majority of
studies in rabbit aorta and mesenteric and coeliac arter-
ies [57], mouse hearts [58], and guinea pig, porcine and
bovine coronary arteries [10, 59, 60]. However, Lewis
and colleagues reported in Wistar rat isolated aortic
preparations that A2a adenosine relaxation was entirely
endothelium-dependent [10], not smooth muscle-
dependent as we found in the present study (Fig. 4a, b).
In rat renal artery, Grbović and colleagues also showed
that removal of the endothelium abolished A2a adeno-
sine relaxation, implicating endothelial relaxation factors
such as NO for relaxation [42]. These contrasting results
may be due to differences in species, age, prior disease
state, aortic ring preparation, presence of an endothe-
lium and the bathing media. Another difference may be
the type of artery; studying the larger arterial conduits
versus smaller arteriolar resistance vessels which have
very different functions (see below ‘Limitations of the
Present Study and Future Studies’). It is noteworthy that
Leal and colleagues found that A2a and A2b subtypes
were abundant in all three layers of Wistar rat thoracic
aorta wall (intima, media, and adventitia) [61], again il-
lustrating the deep complexity of receptor and channel
expression in the thoracic aorta.
Adenosine regulation of relaxation in rat aortic rings: a
working hypothesis
Although we did not investigate adenosine relaxation at dif-
ferent oxygenation states and pH, or from hypoxic animals,
we propose the following scheme. Adenosine-linked NO
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production appeared to be a major endothelium-derived
relaxing factor in intact rat aortic rings, not prostanoids,
which sets the stage for endothelial-smooth muscle coup-
ling. In denuded aortic rings, adenosine appears to activate
A2a receptors and trigger downstream opening of Kv and
KATP channels located on smooth muscle resulting in
membrane hyperpolarization, and relaxation, which may
have involved common protein kinase signalling transduc-
tion pathways and crosstalk [50, 57, 62–66]. Membrane
hyperpolarization of only a few millivolts can lower cyto-
solic Ca2+ via reduced activity of membrane voltage-
operated Ca2+ channels and reduced myofilament Ca2+
sensitivity [67], resulting in smooth muscle relaxation.
Partial support for this hypothesis in denuded rings
comes from reports showing adenosine activation of Kv
channels in pig coronary arterioles occurs via cAMP-
dependent protein kinase (PKA) activation and vaso-
dilatation [68, 69], and from Kleppisch and Nelson who
showed that adenosine A2a (not A2b) activation opens
KATP channels via the cAMP/PKA pathway in isolated
rabbit mesenteric vascular smooth muscle cells [57].
More recently, Maimon and colleagues showed in skel-
etal muscle arterioles that PKA signalling varies with
pre-exposure to adenosine, and that PKA activation
alone was not sufficient to dilate these arterioles, and
required other Ca2+-dependent mechanisms to facilitate
vasodilation to adenosine [66].
Another possible mechanism coupling adenosine A2a
receptor to opening Kv and KATP channels in rat de-
nuded aorta rings may be via mitochondrial production
of H2O2 [70, 71]. H2O2 is a highly diffusible and signal-
ling redox intermediate produced during mitochondrial
phosphorylation of ADP to ATP, and is believed to trig-
ger Ca2+ sparks that activate protein kinase pathways
and adenosine relaxation [72, 73]. Dick and colleagues
reported that H2O2 activated Kv channels and led to cor-
onary vasodilation along with increases in myocardial me-
tabolism [72], and Sharifi-Saniani and colleagues showed
that adenosine A2a receptor activation in mouse aorta
during reactive hyperemia was coupled to smooth muscle
KATP channels via the production of H2O2 [73]. It is
possible that mitochondrial H2O2 bursts may also facili-
tate crosstalk between mito- and sarc-KATP channels in
our model.
Lastly, activation of A2a in rat aortic rings may also have
occurred from adenosine’s breakdown metabolite, inosine
(via adenosine deaminase), which has recently been shown
to be a functional agonist of the A2a receptor [74]. It is pos-
sible therefore that adenosine engages A2a receptor to gen-
erate initial relaxation followed by a dual agonist-mediated
response from inosine to amplify or prolong A2a activation
in vivo. While inosine is known to relax aortic rings [75],
its dual action with adenosine has only been studied in in-
flammatory/immune cells [74].
Limitations of the present study and future studies
While all four major types of K+ channels (Kv, KATP, KIR
and KCa) appear to be present in vascular endothelial and
smooth muscle cells [50, 52, 64, 71, 76, 77], we limited
our study to KV and KATP channels in intact and denuded
aortic rings. We also investigated aortic ring relaxation in
a high pO2 environment and it would be of interest to in-
vestigate the effect of lowering pO2 and changing pH. In
addition, adenosine receptor characterization may have
been more robust with the use of more than one A2a and
A2b antagonist at appropriate concentrations. The isolated
aortic ring preparation also lacks sympathetic neurohu-
moral innervations and the vasa vasorum, which makes
translation to the intact vessel challenging. The in vivo
significance of our results may relate to regulating compli-
ance of the thoracic aorta as part of ventricular-arterial
coupling [78–80]. The thoracic aorta and other large
arteries are compliance vessels and are continually sub-
jected to different hemodynamic forces such as mechan-
ical stretch due to pulsatile blood flow, and may adjust
vascular tone by changing the balance of vasodilating and
vasoconstricting factors and neurohumoral mechanisms
[78–80]. In contrast, smaller peripheral and coronary arte-
rioles supply vascular beds and regulate flow by changing
resistance to maintain adequate tissue oxygenation. Fur-
ther studies are required to investigate the possible role of
adenosine (and possibly inosine) and its various receptor
subtypes to regulate compliance versus resistance vessels
(including venous capacitance vessels) in different regions
and vascular beds in the body.
Conclusions
It was concluded that adenosine relaxation in NE-
precontracted rat thoracic aortic rings was triphasic
and partially endothelium-dependent, and involved
endothelial NO production with a complex interplay
between smooth muscle A2a subtype and voltage-
dependent Kv, SarcKATP and MitoKATP channels, but
not a prostanoid-dependent pathway.
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